Iceland· IS-EU/1/15/1016/001
Repatha
A evolocumab product containing evolocumabum inn, registered in Iceland by Amgen Europe B.V.*. The same ATC class is registered in 15 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Evolocumab is registered in 15 of 19 countries.
Countries holding a registration under ATC C10AX13 (evolocumab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Evolocumab · ATC C10AX13
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of evolocumab costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Evolocumab · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$17.24
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Evolocumabum INN
- Manufacturer
- Amgen Europe B.V.*
- Country
- Iceland (IS)
- ATC code
- C10AX13
- ATC class
- Evolocumab
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 3
3 priced- ean0976031 áf-penni x1 pakkiISK 43731
- ean3772496 áf-penni x1 pakkiISK 193222
- ean5863122 áf-penni x1 pakkiISK 83075
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Evolocumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREPATHAAmgen Europe B.V., Breda
- SpainREPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAAmgen Europe B.V.
- United KingdomRepatha 140mg/1ml solution for injection pre-filled syringesAmgen Ltd
- SwedenRepatha 140 mg Injektionsvätska, lösning i förfylld injektionspennaAmgen Europe B.V.
- BelgiumRepatha 140 mgAmgen Europe
- NorwayRepathaAmgen Europe B.V.
- PolandRepathaAmgen Europe B.V.
- United StatesREPATHAAmgen USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Norway · Repatha
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef4d1fa4-1fc6-44ff-8bc1-b916abbae91e GET /v1/drugs/ef4d1fa4-1fc6-44ff-8bc1-b916abbae91e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "C10AX13",
"marketed": false,
"strength": "140 mg",
"ma_number": "EU/1/15/1016/001",
"substance": "Evolocumabum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "42202"
}See everything about evolocumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.